| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. | Chief Legal Officer | Common Stock | 123,143 | $547,986 | $4.45 | 21 Feb 2025 | Direct |
| Voyager Therapeutics, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 83,000 | 21 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | 21 Feb 2025 | 2 | $0 | 4 | Chief Legal Officer | 24 Feb 2025, 16:18 |
| VYGR | Voyager Therapeutics, Inc. | 11 Feb 2025 | 1 | -$19,393 | 4 | Chief Legal Officer | 12 Feb 2025, 16:19 |
| VYGR | Voyager Therapeutics, Inc. | 02 Oct 2024 | 1 | -$34,914 | 4 | Chief Legal Officer | 03 Oct 2024, 16:43 |
| VYGR | Voyager Therapeutics, Inc. | 09 Feb 2024 | 2 | $0 | 4 | Chief Legal Officer | 16 Feb 2024, 17:06 |
| VYGR | Voyager Therapeutics, Inc. | 01 Oct 2023 | 1 | $0 | 4 | Chief Legal Officer | 02 Oct 2023, 16:24 |
| VYGR | Voyager Therapeutics, Inc. | 10 Jul 2023 | 1 | $0 | 4 | Chief Legal Officer | 11 Jul 2023, 16:46 |
| VYGR | Voyager Therapeutics, Inc. | 10 Jul 2023 | 0 | $0 | 3 | Chief Legal Officer | 11 Jul 2023, 16:46 |